-transparent.png){kind=logo}
The factors that control migration of mast cells to sites of inflammation and tissue repair remain largely undefined. Whereas several recent studies have described chemotactic factors that induce migration of murine mast cells, only stem cell factor (SCF) is known to induce migration of human mast cells. We report here that the anaphylatoxins C3a and C5a are chemotactic factors for the human mast cell line HMC-1, human cord blood-derived mast cells (CBMC) and cutaneous mast cells in vitro. The presence of an extracellular matrix protein, laminin, was required for chemotaxis in response to complement peptides. Migration of mast cells towards C3a and C5a was dose-dependent, peaking at 1 microg/mL (100 nmol/L), and was inhibited by specific antibodies. Pretreatment with pertussis toxin inhibited the anaphylatoxin-mediated migration of HMC-1 cells, indicating that Gi proteins are involved in complement-activated signal transduction pathways in human mast cells. Both C3a and C5a also induced a rapid and transient mobilization of intracellular free calcium ([Ca2+]i) in HMC-1 cells. Besides SCF, other chemotactic factors tested, such as interleukin-3, nerve growth factor, transforming growth factor beta, RANTES (regulated upon activation, normal Tcell expressed and secreted), monocyte chemotactic protein-1 (MCP-1), MCP-2, MCP-3, macrophage inflammatory protein-1alpha (MIP-1alpha), and MIP-1beta, failed to stimulate migration of human mast cells. In summary, these findings indicate that C3a and C5a serve as chemotaxins for human mast cells. Anaphylatoxin-mediated recruitment of mast cells might play an important role in hypersensitivity and inflammatory processes.
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
January 1997,
Experimental and clinical immunogenetics,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
May 1994,
The Journal of investigative dermatology,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
January 2010,
Immunology letters,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
November 2006,
The Journal of investigative dermatology,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
June 1975,
Immunology,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
February 2013,
Protein science : a publication of the Protein Society,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
April 1986,
Agents and actions,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
January 1978,
Advances in immunology,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
October 2005,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
K Hartmann, and
B M Henz, and
S Krüger-Krasagakes, and
J Köhl, and
R Burger, and
S Guhl, and
I Haase, and
U Lippert, and
T Zuberbier
November 1999,
Nihon rinsho. Japanese journal of clinical medicine,
